“The Challenge provided an unique and incredible opportunity to get involved in developing a life-saving breast cancer technology, and we’re excited to have put together such a strong team that will work hard to bring a product with multiple medical indications to market for the benefit of breast cancer patients worldwide. We would like to thank everyone involved in the Challenge, especially CAI, the Avon Foundation, and Dr. Burg and her team at Clemson University. Finally, we want to extend a special thanks to Shafin Khan and his commercialization team at New Orleans BioInnovation Center for their continued support of our entrepreneurial efforts."